Our trial of ondansetron as a treatment for hallucinations in Parkinson's is restarting Date 22 November 2024
Research shows targeting LRRK2 could benefit many with Parkinson's Date 27 July 2018 New research highlights importance of LRRK2 as a pivotal player in all kinds of Parkinson's, not just genetic forms.
Diabetes-type drug may slow Parkinson's Date 3 July 2018 Researchers in America have developed an experimental drug, similar to compounds used to treat diabetes, that slows the progression of Parkinson's in a mouse model of the condition.
Study finds potential benefits of vitamin B3 Date 7 June 2018 Researchers have discovered that nicotinamide riboside, a form of vitamin B3, may boost energy in nerve cells and help prevent them being lost in Parkinson's.
Exenatide found to have positive effect on mood Date 31 May 2018 Further analysis of the results from a recent clinical trial of the type 2 diabetes drug exenatide in people with Parkinson's has revealed encouraging signs of a positive effect on mood.
UK-wide trial to test treatment for balance, walking and falls Date 29 May 2018 The trial will test whether drug treatment with a commonly prescribed dementia drug can improve balance and walking and help to prevent falls in people with Parkinson's.
Artificial intelligence to help develop new Parkinson’s treatments Date 27 March 2018 We are pleased to announce that a Parkinson's research project has been awarded the inaugural BenevolentAI Award. The project will use an artificial intelligence platform’s capabilities to reason, deduce and suggest entirely new treatments for Parkinson’s.
Studying human brain tissue in 3D Date 14 March 2018 An international team has developed a cutting-edge technique, enabling human brain tissue to be studied in 3D.
Calcium may play a role in Parkinson's Date 19 February 2018 New international research suggests that too much calcium inside brain cells may trigger a chain reaction that leads to Parkinson's.
Investing in a new treatment for dyskinesia Date 24 January 2018 We're partnering with US company Neurolixis to accelerate the development of a drug that could prevent dyskinesia, a debilitating side effect of Parkinson's medication.
Research into flu and the onset of Parkinson's Date 16 January 2018 A study, featured in the Daily Mail, suggests a link between certain types of flu and risk of Parkinson's.
